Literature DB >> 26069280

Total Plasma Homocysteine Level Assessment and Timing of Folate/B12 Supplementation Prior to Initiation of Pemetrexed-Based Chemotherapy for Nonsquamous Non-Small Cell Lung Cancer Patients: An Irrelevant Investigation, an Unnecessary Delay, or Both?

Navneet Singh1, Venkata Nagarjuna Maturu1, Digambar Behera1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26069280      PMCID： PMC4492244          DOI： 10.1634/theoncologist.2015-0040

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  6 in total

1.  Commentary: a case for minimizing folate supplementation in clinical regimens with pemetrexed based on the marked sensitivity of the drug to folate availability.

Authors:  Shrikanta Chattopadhyay; Roni Tamari; Sang H Min; Rongbao Zhao; Eugenia Tsai; I David Goldman
Journal:  Oncologist       Date:  2007-07

2.  A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.

Authors:  Yusuke Takagi; Yukio Hosomi; Kuniko Sunami; Yoshiro Nakahara; Yusuke Okuma; Makiko Yomota; Tsuneo Shimokawa; Makoto Nagamata; Mari Iguchi; Hiroaki Okamoto; Tatsuru Okamura; Masahiko Shibuya
Journal:  Oncologist       Date:  2014-09-26

Review 3.  Management of advanced lung cancer in resource-constrained settings: a perspective from India.

Authors:  Navneet Singh; Ashutosh N Aggarwal; Digambar Behera
Journal:  Expert Rev Anticancer Ther       Date:  2012-11       Impact factor: 4.512

4.  The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.

Authors:  Young Saing Kim; Jong-Mu Sun; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park
Journal:  Lung Cancer       Date:  2013-05-14       Impact factor: 5.705

5.  Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.

Authors:  Navneet Singh; Ashutosh N Aggarwal; Jyotdeep Kaur; Digambar Behera
Journal:  Am J Clin Oncol       Date:  2017-02       Impact factor: 2.339

6.  Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series.

Authors:  Benjamin R Griffin; Elisabeth K Stephens; Aminah Jatoi
Journal:  Case Rep Oncol       Date:  2013-06-26
  6 in total
  2 in total

1.  In Reply.

Authors:  Yusuke Takagi; Yukio Hosomi; Masahiko Shibuya; Hiroaki Okamoto
Journal:  Oncologist       Date:  2015-06-11

2.  A Mendelian Randomization Study of Plasma Homocysteine and Multiple Myeloma.

Authors:  Yang Xuan; Xiao-Hong Li; Zhong-Qian Hu; Zhi-Mei Teng; Dao-Jun Hu
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.